Policies about physicians' involvement with pharmaceutical companies spawn contradictory ideas. One set of policies aims to stimulate collaboration between private companies and publicly employed researchers to spur innovation and economic growth, another addresses what is seen as the problem of physicians' conflicts of interest stemming from industry collaboration. This article explores how these contradictory policies interact with everyday practice in clinical hypertension research in Denmark. I argue that `corporate' and `academic' research is entangled as physicians participate in industry trials to pursue their own research. Building on document analysis, observations of contract research, and interviews with clinician researchers and industry executives, I show how the establishment of industry `ties' can serve as a way for physicians to navigate the constraints of research infrastructures and live up to intergenerational norms that knit the medical collective together. I discuss how this entanglement shapes medical research in ways that may run counter to the aims of medical innovation policies and that conflicts of interest policies do little to address. I conclude that appreciation of the ways in which economic and moral valuations come together is necessary to understand the conditions for medical research in an intertwined public--private research environment.
...More
Book
Jonathan Engel;
(2018)
Unaffordable: American Healthcare from Johnson to Trump
(/isis/citation/CBB064961709/)
Article
Bonah, Christian;
(2013)
“The Strophanthin Question”: Early Scientific Marketing of Cardiac Drugs in Two National Markets (France and Germany, 1900--1930).
(/isis/citation/CBB001320753/)
Article
Klaus Hoeyer;
Aaro Tupasela;
Malene Bøgehus Rasmussen;
(May 2017)
Ethics Policies and Ethics Work in Cross-national Genetic Research and Data Sharing
(/isis/citation/CBB887043244/)
Article
Carreta, Jorge Augusto;
(2011)
Oswaldo Cruz e a controvérsia da sorologia
(/isis/citation/CBB001420533/)
Thesis
Quinn, Roswell;
(2009)
Broader Spectrum: A History of Antibiotic R&D
(/isis/citation/CBB001560664/)
Article
Quirke, Viviane;
(2014)
Targeting the American Market for Medicines, ca. 1950s–1970s: ICI and Rhône-Poulenc Compared
(/isis/citation/CBB001202354/)
Article
Jones, David S.;
(2000)
Visions of a Cure: Visualization, Clinical Trials, and Controversies in Cardiac Therapeutics, 1968-1998
(/isis/citation/CBB000111163/)
Article
Berman, Elizabeth Popp;
(2014)
Not Just Neoliberalism: Economization in US Science and Technology Policy
(/isis/citation/CBB001421198/)
Article
Rosa Nan Leunbach;
Kristian H. Nielsen;
(2019)
Exploring the Dialogical Space of Hybrid Forums: The “Predictably Unpredictable” Case of Radioactive Waste Management in Denmark, 2003-2018
(/isis/citation/CBB878608684/)
Article
Forsdyke, Donald R.;
(2012)
Immunology (1955--1975): The Natural Selection Theory, the Two Signal Hypothesis and Positive Repertoire Selection
(/isis/citation/CBB001221000/)
Article
Danya Glabau;
(2017)
Conflicting Assumptions: The Meaning of Price in the Pharmaceutical Economy
(/isis/citation/CBB838843938/)
Article
Nielsen, Henry;
Knudsen, Henrik;
(2013)
Too Hot to Handle: The Controversial Hunt for Uranium in Greenland in the Early Cold War
(/isis/citation/CBB001212895/)
Book
Mikkael A. Sekeres;
(2022)
Drugs and the FDA: Safety, Efficacy, and the Public's Trust
(/isis/citation/CBB614307145/)
Article
Margaret E. MacDonald;
(March 2021)
Misoprostol: The Social Life of a Life-saving Drug in Global Maternal Health
(/isis/citation/CBB680292467/)
Article
Cho, Hyun-Dae;
Lee, Byung-Heon;
Sung, Tae-Kyung;
Kim, Sun-Woo;
(2011)
Assessing the Institutional Legitimacy of Research and Technology Organisations in South Korea: A Content Analysis Approach
(/isis/citation/CBB001201772/)
Article
Shimamoto, Minoru;
(2011)
R&D Strategy and Knowledge Creation in Japanese Chemical Firms, 1980--2010
(/isis/citation/CBB001211694/)
Book
Radder, Hans;
(2010)
The Commodification of Academic Research: Science and the Modern University
(/isis/citation/CBB001033317/)
Article
Reiko Kanazawa;
(2022)
Pricing Retrovir: Wellcome PLC and the Role of Pharmaceutical Companies in the Global AIDS Crisis, 1986 to 1991
(/isis/citation/CBB674974403/)
Article
Ghosh, Saibal;
(2011)
R&D in Public Enterprises: An Empirical Investigation for India
(/isis/citation/CBB001201769/)
Chapter
Shintaro Sengoku;
(2019)
Consortium-Based Open Innovation: Exploring a Unique and Optimal Model for Regional Biotechnology Industry
(/isis/citation/CBB149339845/)
Be the first to comment!